Sublingual allergen immunotherapy in HIV‐positive patients
- 24 December 2015
- Vol. 71 (3), 412-415
- https://doi.org/10.1111/all.12713
Abstract
HIV infection is a relative contraindication for allergic immunotherapy (AIT). In the last decade, highly active antiretroviral therapy (HAART) has improved the immune function and life expectancy in HIV-infected patients whose respiratory allergic incidence is similar to the general population. We evaluated the safety and clinical effectiveness of sublingual immunotherapy in a group of grass pollen-allergic HAART-treated HIV-positive patients. Thirteen patients received sublingual immunotherapy (SLIT) tablet (Oralair, Stallergenes©) and symptomatic therapy and were compared with nine patients receiving symptomatic therapy alone. Clinical benefits were evaluated by the analysis of total combined score (TCS), sum of symptom–medication score, and a quality of life (QoL) questionnaire. HIV viral load and peripheral TCD4 lymphocytes were analyzed at the beginning and at the end of the study. Clinical efficacy data showed a significant improvement in SLIT-treated patients compared to controls (TCS: P = 0.0001; QoL: P = 0.03). We did not observe any significant alteration of TCD4 cell counts and viral load (VL) in both groups. Our preliminary data showed that SLIT therapy in viro-immunological controlled HAART treated HIV positive patients was efficacious, safe and well tolerated.This publication has 14 references indexed in Scilit:
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAIDS, 2013
- Allergen immunotherapy: A practice parameter third updateJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsJournal of Allergy and Clinical Immunology, 2011
- Influence of a Vaccination Schedule on Viral Load Rebound and Immune Responses in Successfully Treated HIV-Infected PatientsAIDS Research and Human Retroviruses, 2009
- Pneumococcal and influenza immunization and human immunodeficiency virus load in childrenThe Pediatric Infectious Disease Journal, 2000
- Predictors of atopy in HIV-infected patientsAnnals of Allergy, Asthma & Immunology, 2000
- AIDS, HIV-Positive Patients, and AllergiesAllergy and Asthma Proceedings, 1999
- Validation of the standardized version of the Rhinoconjunctivitis Quality of Life QuestionnaireJournal of Allergy and Clinical Immunology, 1999
- Prévalence des manifestations cliniques évocatrices d'allergie au cours de l'infection par le VIH. Étude transversale de 115 sujetsLa Revue de Médecine Interne, 1997
- Clinical Manifestations of Allergy and Their Relation to HIV InfectionInternational Archives of Allergy and Immunology, 1993